Superworth

Align Technology EV/EBIT ALGN

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2011.

Today, Oct 23, 2026
16.2×
10-year median
35.3×
Against its 10-year history
5th
percentile: 0 is its lowest day, 100 its highest
10-year range
13.0× to 149×
Peer median
19.2×

Align Technology's EV/EBIT is 16.2× as of Oct 23, 2026.

That is below its ten-year median of 35.3×, lower than on 95% of days in the last ten years.

Over that time it ranged from 13.0× in Oct 2025 to 149× in Feb 2021.

The median for 10 medical instruments and supplies stocks of a similar size is 19.2×.

EV/EBIT over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far16.2×14.8×20.9×
202516.8×13.0×24.2×
202421.8×21.8×38.7×
202333.2×21.7×48.5×
202220.6×15.4×45.4×
202154.8×50.7×149×
2020128×20.3×133×
201943.0×27.2×60.5×
201835.2×33.6×75.4×
201754.9×27.7×66.4×
201629.4×23.2×34.2×
201526.3×17.3×27.1×
201418.6×15.6×35.0×
201331.0×14.7×34.7×
201215.5×14.4×26.7×
201120.7×10.7×22.3×

Against its peers

Companies in Medical - Instruments & Supplies nearest Align Technology's size, closest first, today.

CompanyEV/EBIT
ALGNAlign Technology16.2×
GMEDGlobus Medical16.3×
COOCooper Companies17.2×
PODDInsulet20.4×
PENPenumbra65.8×
SOLVSolventum8.4×
MSAMSA Safety18.0×
MMSIMerit Medical Systems28.6×
HAEHaemonetics26.8×
VNTVontier10.9×
BMIBadger Meter26.2×
Peer median19.2×

Where Align Technology ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Align Technology

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.